| P2093 | author name string | Puneeta Tandon | |
| | Guadalupe Garcia-Tsao | |
| | Roberto J Groszmann | |
| | Michael Tal | |
| | Irteza Inayat | |
| | Marcelo Spector | |
| | Martha Shea | |
| P2860 | cites work | Potency, selectivity, and consequences of nonselectivity of PDE inhibition | Q28269129 |
| | Evidence for expression and function of phosphodiesterase type 5 (PDE-V) in rat resistance arteries | Q28345798 |
| | Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers | Q28582476 |
| | Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review | Q33263463 |
| | Molecular mechanism of cGMP-mediated smooth muscle relaxation | Q33980649 |
| | Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. | Q34469981 |
| | Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunction. | Q35569263 |
| | The hepatic venous pressure gradient: anything worth doing should be done right | Q35651680 |
| | Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis | Q37386601 |
| | Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme | Q42951390 |
| | Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. | Q44385938 |
| | Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites. | Q45197565 |
| | Acute administration of sildenafil enhances hepatic cyclic guanosine monophosphate production and reduces hepatic sinusoid resistance in cirrhotic patients | Q46480928 |
| | Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study | Q46879609 |
| | Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues. | Q48828424 |
| | Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. | Q51091239 |
| | Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels | Q73198479 |
| | Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats | Q77355535 |
| | Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis | Q82853308 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 546-549 | |
| P577 | publication date | 2010-02-06 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Sildenafil has no effect on portal pressure but lowers arterial pressure in patients with compensated cirrhosis | |
| P478 | volume | 8 | |